Neil E. Bhola
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- DNA Repair Mechanisms 4
- Cancer-related gene regulation 3
- Oncology 22
- Cancer-related Molecular Pathways 7
- Cancer Cells and Metastasis 7
- Peptidase Inhibition and Analysis 4
- HER2/EGFR in Cancer Research 3
- Co-authors
- Carlos L. Arteaga (12 shared papers)Jennifer R. Grandis (18 shared papers)Justin M. Balko (4 shared papers)Melinda E. Sanders (4 shared papers)Teresa C. Dugger (3 shared papers)M. Gabriela Kuba (2 shared papers)Violeta Sánchez (2 shared papers)Rebecca S. Cook (1 shared paper)
- Journals
- Cancer Research (16 papers)Clinical Cancer Research (4 papers)Molecular Cancer Therapeutics (2 papers)Head & Neck (1 paper)PROTEOMICS (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Neil E. Bhola
36 papers receiving 2.1k citations
Neil E. Bhola's Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 1.0k
- Cancer Research 440
- Molecular Biology 1.2k
- Genetics 119
- Pulmonary and Respiratory Medicine 341
Countries citing papers authored by Neil E. Bhola
This map shows the geographic impact of Neil E. Bhola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil E. Bhola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil E. Bhola more than expected).
Fields of papers citing papers by Neil E. Bhola
This network shows the impact of papers produced by Neil E. Bhola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil E. Bhola. The network helps show where Neil E. Bhola may publish in the future.
Co-authors
The 25 scholars most cited alongside Neil E. Bhola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer Hit paper breakdown → | 2013 | 499 |
| 2 | 2012 | 206 | |
| 3 | 2017 | 180 | |
| 4 | 2017 | 174 | |
| 5 | 2013 | 127 | |
| 6 | 2006 | 119 | |
| 7 | 2012 | 106 | |
| 8 | 2010 | 92 | |
| 9 | 2016 | 87 | |
| 10 | 2015 | 80 | |
| 11 | 2018 | 73 | |
| 12 | 2007 | 72 | |
| 13 | 2014 | 51 | |
| 14 | 2016 | 46 | |
| 15 | 2019 | 38 | |
| 16 | 2015 | 32 | |
| 17 | 2018 | 31 | |
| 18 | 2008 | 31 | |
| 19 | 2011 | 25 | |
| 20 | 2012 | 22 |
About Neil E. Bhola
Neil E. Bhola is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Cancer Research, having authored 36 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Cancer Cells and Metastasis (7 papers), Lung Cancer Treatments and Mutations (5 papers), DNA Repair Mechanisms (4 papers), Head and Neck Cancer Studies (4 papers), Peptidase Inhibition and Analysis (4 papers), Cancer-related gene regulation (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (440 citations), Molecular Biology (1.2k citations), Genetics (119 citations) and Pulmonary and Respiratory Medicine (341 citations). Neil E. Bhola has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Carlos L. Arteaga, Jennifer R. Grandis, Justin M. Balko, Melinda E. Sanders, Teresa C. Dugger, M. Gabriela Kuba, Violeta Sánchez, Rebecca S. Cook, Jamie C. Stanford and Sufi M. Thomas. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Molecular Cancer Therapeutics, Head & Neck and PROTEOMICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.